Morgan Henry

Director at BIOSPECIFICS TECHNOLOGIES CORP

Sold, on record
$2.3M
Dollars the filings state
Form 4 sales
8
Latest Jun 4, 2014
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusual
    Dec 14, 2009 2009

    Sold 11,454 shares at $30.05 ($344k)

    Morgan Henry, Director

    Sold 26.3% of holdings ($1.3M position)32,074 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    Dec 15, 2009 +1 day

    Sold 306 shares at $30.31 ($9k)

    Morgan Henry, Director

    Sold 1% of holdings ($972k position)31,768 shares leftFiling

  3. 3 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    Sep 3, 2013 +1358 days

    Sold 2,150 shares at $18.34 ($39k)

    Morgan Henry, Director

    Sold 5.8% of holdings ($682k position)35,043 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusual
    Sep 5, 2013 +2 days

    Sold 17,850 shares at $18.48 ($330k)

    Morgan Henry, Director

    Sold 50.9% of holdings ($648k position)17,193 shares leftFiling

  5. 5 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusual
    May 19, 2014 +256 days

    Sold 20,000 shares at $25.84 ($517k)

    Morgan Henry, Director

    Sold 53.8% of holdings ($961k position)17,193 shares leftFiling

  6. 6 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusual
    May 29, 2014 +10 days

    Sold 20,000 shares at $27.04 ($541k)

    Morgan Henry, Director

    Sold 35% of holdings ($1.5M position)37,193 shares left1.1x usual sizeFiling

  7. 7 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    Jun 2, 2014 +4 days

    Sold 2,060 shares at $27.01 ($56k)

    Morgan Henry, Director

    Sold 5.5% of holdings ($1M position)35,133 shares left0.1x usual sizeFiling

  8. 8 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusual
    Jun 4, 2014 +2 days

    Sold 17,940 shares at $27.00 ($484k)

    Morgan Henry, Director

    Sold 51.1% of holdings ($949k position)17,193 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Morgan Henry
Source
Jun 4, 2014Jun 5, 2014BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale17,940$484k51.1%UnusualSEC
Jun 2, 2014Jun 3, 2014BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale2,060$56k5.5%Plan not statedSEC
May 29, 2014May 30, 2014BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale20,000$541k35.0%UnusualSEC
May 19, 2014May 21, 2014BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale20,000$517k53.8%UnusualSEC
Sep 5, 2013Sep 6, 2013BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale17,850$330k50.9%UnusualSEC
Sep 3, 2013Sep 4, 2013BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale2,150$39k5.8%Plan not statedSEC
Dec 15, 2009Dec 17, 2009BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale306$9k1.0%Plan not statedSEC
Dec 14, 2009Dec 15, 2009BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale11,454$344k26.3%UnusualSEC